当前位置: 首页 > 详情页

miR-150-5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China [2]Department of Pathology, Xiongan Xuanwu Hospital, Xiongan New Area, China [3]Department of Oncology‐Pathology, Karolinska Institutet,BioClinicum J6:20, Karolinska University Hospital, Solna, Sweden [4]Tianjin Key Laboratory of Exercise Physiology and Sports Medicine, Institute of Sport, Exercise and Health, Tianjin University of Sports, Tianjin, China
出处:
ISSN:

关键词: CTNNB1 FTO Merkel cell carcinoma miR‐150‐5p RNA N6‐methyladenosine modification

摘要:
MicroRNAs (miRNAs) are small regulatory molecules playing important roles in different physiological and pathological processes, but only several miRNAs were functionally characterized in Merkel cell carcinoma (MCC). We previously identified miR-150-5p as one of the differentially expressed miRNAs between MCC metastases and primary tumors. In the present study, we further investigated the functional role of miR-150-5p in MCC progression. Our results revealed that miR-150-5p suppresses the migratory and invasive properties of MCC cells. We identified RNA N6-methyladenosine (m6A) demethylase FTO as a direct target of miR-150-5p. Functionally, we showed that FTO enhances proliferative, migratory and invasive properties of MCC cells, and rescued the antitumor effects induced by miR-150-5p. Mechanistically, we demonstrated that FTO stabilizes CTNNB1 transcripts via its m6A demethylation activity. Silencing the m6A reader YTHDF2 increased, while its overexpression decreased CTNNB1 mRNA and protein levels. Furthermore, the RNA immunoprecipitation assays demonstrated the interaction between CTNNB1 mRNA and YTHDF2. Together, these results suggest that FTO stabilizes CTNNB1 in an m6A-dependent manner. In conclusion, our findings uncover the role of miR-150-5p and its target FTO in MCC progression, suggesting the potential of targeting FTO signaling for MCC therapy.© 2025 Wiley Periodicals LLC.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 4 区 医学
小类 | 3 区 生化与分子生物学 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 生化与分子生物学 4 区 肿瘤学
第一作者:
第一作者机构: [1]Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:18203 今日访问量:0 总访问量:996 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院